A new treatment described as 'ground-breaking' could help to save your sight.
Broadhurst Optometrists, with practices in Preston and Lytham, are among the first in the UK to offer the Valeda Light Delivery System, the only approved device for treating dry age-related macular degeneration (AMD).
AMD is the leading cause of central vision loss in older adults and affects tasks like reading, driving, and recognising faces.
Lynsey Arguello, director at Broadhurst Optometrists, said: "This is a truly ground-breaking treatment and we are very proud to be able to offer this to our patients and the wider community.
"Valeda provides revolutionary evidence-based treatment for dry AMD, which until recently didn’t have any form of treatment.
"The fact that this procedure is so simple and painless is also a huge benefit."
The Valeda system uses photo-biomodulation (PBM) to apply specific wavelengths of light to the eye, stimulating energy production in ageing retinal cells.
The treatment aims to slow, and in some cases, reverse, the progression of dry AMD.
READ MORE:
- New Wegovy weight loss pill is now available in pharmacies – here's how much it costs
- Jet2 adds six 'stunning' new destinations to their holiday package lists
- School upgrades and waste projects in latest Lancashire planning applications
Ms Arguello said: "With this technology, we’re able to treat the condition at the earliest possible stage, allowing our patients to see better for longer.
"Considering the practice’s history of pushing the boundaries of what’s possible in eye care, this is the perfect piece of equipment to offer to our patients and we’re really looking forward to seeing the local community benefit from the latest advancements in the optical industry."
The device is now available at both Preston and Lytham practices.
Share